Global Generic Drugs Market 2014-2018
WEST HARTFORD, Conn., April 21, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Global Generic Drugs Market 2014-2018" at GIIResearch.com
TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market.
TechNavio's report, the Global Generic Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Generic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Actavis plc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.
Table of Contents
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Market Segmentation by Category
- Market Segmentation by Therapeutic Applications
- Geographical Segmentation
- Key Leading Countries
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
- Other Reports in this Series
List of Exhibits
More detailed information is available at
Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, USfirstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.